These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28691227)

  • 21. Biased agonists of GPR84 and insights into biological control.
    Luscombe VB; Wang P; Russell AJ; Greaves DR
    Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.
    Nguyen ATN; Nguyen DTN; Koh HY; Toskov J; MacLean W; Xu A; Zhang D; Webb GI; May LT; Halls ML
    Br J Pharmacol; 2024 Jul; 181(14):2371-2384. PubMed ID: 37161878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protease-activated receptor 4: from structure to function and back again.
    French SL; Hamilton JR
    Br J Pharmacol; 2016 Oct; 173(20):2952-65. PubMed ID: 26844674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of oxidative stress: translational opportunities.
    Daiber A; Di Lisa F; Ferdinandy P
    Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingolipids in the function of G protein-coupled receptors.
    Jafurulla M; Chattopadhyay A
    Eur J Pharmacol; 2015 Sep; 763(Pt B):241-6. PubMed ID: 26164794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unravelling G protein-coupled receptor signalling networks using global phosphoproteomics.
    Pokhrel R; Morgan AL; Robinson HR; Stone MJ; Foster SR
    Br J Pharmacol; 2024 Jul; 181(14):2359-2370. PubMed ID: 36772927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology.
    Dunn HA; Orlandi C; Martemyanov KA
    Pharmacol Rev; 2019 Oct; 71(4):503-519. PubMed ID: 31515243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.
    Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT
    Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.
    Little PJ; Hollenberg MD; Kamato D; Thomas W; Chen J; Wang T; Zheng W; Osman N
    Br J Pharmacol; 2016 Oct; 173(20):2992-3000. PubMed ID: 26624252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function and regulation of GPR84 in human neutrophils.
    Forsman H; Dahlgren C; Mårtensson J; Björkman L; Sundqvist M
    Br J Pharmacol; 2024 May; 181(10):1536-1549. PubMed ID: 36869866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting G protein-coupled receptors for heart failure treatment.
    Thai BS; Chia LY; Nguyen ATN; Qin C; Ritchie RH; Hutchinson DS; Kompa A; White PJ; May LT
    Br J Pharmacol; 2024 Jul; 181(14):2270-2286. PubMed ID: 37095602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
    Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
    Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
    Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
    Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.
    Sengmany K; Gregory KJ
    Br J Pharmacol; 2016 Oct; 173(20):3001-17. PubMed ID: 26276909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
    Marino KA; Shang Y; Filizola M
    Br J Pharmacol; 2018 Jul; 175(14):2834-2845. PubMed ID: 28266020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C; Nijmeijer S; Wolf S; Ernst OP
    Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial membrane-like environments for in vitro studies of purified G-protein coupled receptors.
    Serebryany E; Zhu GA; Yan EC
    Biochim Biophys Acta; 2012 Feb; 1818(2):225-33. PubMed ID: 21851807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WNT signalling: mechanisms and therapeutic opportunities.
    Schulte G; Bryja V
    Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane cholesterol in the function and organization of G-protein coupled receptors.
    Paila YD; Chattopadhyay A
    Subcell Biochem; 2010; 51():439-66. PubMed ID: 20213554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.